Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation
2025

Radiotherapy and Inflammation in Prostate Cancer

Sample size: 306 publication Evidence: moderate

Author Information

Author(s): Paal Katarzyna, Stranz Bettina, Thurner Eva-Maria, Niedrist Tobias, Renner Wilfried, Langsenlehner Tanja

Primary Institution: Medical University of Graz

Hypothesis

Does prostate cancer radiotherapy influence systemic inflammation and contribute to aging-related conditions?

Conclusion

Radiation therapy triggers chronic inflammatory processes that may worsen age-related conditions.

Supporting Evidence

  • Radiotherapy significantly increased levels of inflammatory markers like fibrinogen and NLR.
  • Cholesterol and albumin levels decreased during treatment but showed some recovery afterward.
  • Fibrinogen levels remained elevated 15 months post-treatment compared to baseline.

Takeaway

This study found that radiation treatment for prostate cancer can cause inflammation, which might make aging-related health issues worse.

Methodology

The study analyzed inflammatory blood parameters in 306 prostate cancer patients before, during, and after radiotherapy.

Limitations

The study lacked a control group for comparison with non-irradiated individuals.

Participant Demographics

Median age was 73 years, with a majority aged 65 and older.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1007/s00345-024-05409-z

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication